A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 5, 2015, Pages H771-H778

  Regan, Jessica A ^a   Gabriele Mauro, Adolfo ^a   Carbone, Salvatore ^a   Marchetti, Carlo ^a   Gill, Rabia ^a   Mezzaroma, Eleonora ^a   Raleigh, Juan Valle ^a   Salloum, Fadi N ^a   Van Tassell, Benjamin W ^a   Abbate, Antonio ^a   Toldo, Stefano ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Angiotensin II; Animal model; Diastolic dysfunction; End diastolic pressure; Heart failure with preserved ejection fraction; Isovolumetric relaxation time

Indexed keywords

ANGIOTENSIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PERFORMANCE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; MALE; MOUSE; MOUSE MODEL; NONHUMAN; OSMOTIC PUMP; PHENOTYPE; PRESSURE TRANSDUCER; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; ANIMAL; DISEASE MODEL; HEART FAILURE; HEART STROKE VOLUME; PATHOLOGY; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART FAILURE; INFUSIONS, SUBCUTANEOUS; MALE; MICE; STROKE VOLUME;

EID: 84940771777     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00282.2015     Document Type: Article

References (29)

1. Abassi Z, Goltsman I, Karram T, Winaver J, Hoffman A. Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol 2011: 729497, 2011
2. Abbate A, Arena R, Abouzaki N, Van Tassell BW, Canada J, Shah K, Biondi-Zoccai G, Voelkel NF. Heart failure with preserved ejection fraction: refocusing on diastole. Int J Cardiol 179: 430–440, 2015
3. Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117: 2670–2683, 2008
4. Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens 13: 31S–38S, 2000
5. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A 103: 10086–10091, 2006
6. Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation 111: 774–781, 2005
7. Daugherty A, Rateri D, Hong L, Balakrishnan A. Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp 27: 1291, 2009
8. Fang JC. Heart failure therapy: what should clinicians believe? J AmMed Assoc 308: 2144–2146, 2012
9. Hamdani N, Franssen C, Lourenco A, Falcao-Pires I, Fontoura D, Leite S, Plettig L, Lopez B, Ottenheijm CA, Becher PM, Gonzalez A, Tschope C, Diez J, Linke WA, Leite-Moreira AF, Paulus WJ. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail 6: 1239–1249, 2013
10. Hillestad V, Kramer F, Golz S, Knorr A, Andersson KB, Christensen G. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene. J Appl Physiol 115: 1572–1580, 2013
11. Horgan S, Watson C, Glezeva N, Baugh J. Murine models of diastolic dysfunction and heart failure with preserved ejection fraction. J Card Fail 20: 984–995, 2014
12. LeWinter MM, Granzier H. Cardiac titin: a multifunctional giant. Circulation 121: 2137–2145, 2010
13. Lund LHBL, Dahlström U, Edner M. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. J Am Med Assoc 20: 2108–2117, 2012
14. Oh JK, Park SJ, Nagueh SF. Established and novel clinical applications of diastolic function assessment by echocardiography. Circ Cardiovasc Imaging 4: 444–455, 2011
15. Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, Takashima S, Hirata A, Fujita M, Nagamachi Y, Nakatani T, Yutani C, Ozawa K, Ogawa S, Tomoike H, Hori M, Kitakaze M. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110: 705–712, 2004
16. Okamoto K. Spontaneous hypertension in rats. Int Rev Exp Pathol 7: 227–270, 1969
17. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251–259, 2006
18. Patten RD, Hall-Porter MR. Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2: 138–144, 2009
19. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite- Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28: 2539–2550, 2007
20. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences in myocardial remodeling. J Am Coll Cardiol 55: 1057–1065, 2010
21. Porter TR, Shillcutt SK, Adams MS, Desjardins G, Glas KE, Olson JJ, Troughton RW. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 28: 40–56, 2015
22. Reil JC, Hohl M, Reil GH, Granzier HL, Kratz MT, Kazakov A, Fries P, Muller A, Lenski M, Custodis F, Graber S, Frohlig G, Steendijk P, Neuberger HR, Bohm M. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J 34: 2839–2849, 2013
23. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16: 349–360, 2004
24. Toldo S, Bogaard HJ, Van Tassell BW, Mezzaroma E, Seropian IM, Robati R, Salloum FN, Voelkel NF, Abbate A. Right ventricular dysfunction following acute myocardial infarction in the absence of pulmonary hypertension in the mouse. PloS One 6: e18102, 2011
25. Tong CW, Nair NA, Doersch KM, Liu Y, Rosas PC. Cardiac myosinbinding protein-C is a critical mediator of diastolic function. Pflügers Arch 466: 451–457, 2014
26. Treskatsch S, Feldheiser A, Rosin AT, Sifringer M, Habazettl H, Mousa SA, Shakibaei M, Schafer M, Spies CD. A modified approach to induce predictable congestive heart failure by volume overload in rats. PloS One 9: e87531, 2014
27. Yamori Y, Ooshima A, Okamoto K. Genetic factors involved in spontaneous hypertension in rats an analysis of F 2 segregate generation. Japn Circ J 36: 561–568, 1972
28. Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122: 717–728, 2010
29. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure–abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350: 1953–1959, 2004.